arrow
Back
I

Ian Chau

The Royal Marsden Hospital

81H-index
847Paper Count
4.5WCitation Count
Published Papers 264
Publication Date
Targeting Phosphatidylserine in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas: A Phase 2 Trial of Bavituximab Plus Pembrolizumab with Biomarker-Correlated Outcomes
err2026-05-28
err0
errOAAI
errPanagiotis Ntellas; Haeseong Park; Kerry Culm; Jeeyun Lee; Hagop Youssoufian; Colleen Mockbee; Mark Uhlik; Laura Benjamin; Ian Chau
errShare
errSave
Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma—UK Tertiary Cancer Centre Experience
errCancers
IF4.4
err2026-05-16
err0
errOAAI
errKai Tai Derek Yeung; Simon Gomberg; William Hodgson; Petula Jefferies; David Cunningham; Sheela Rao; Ian Chau; Naureen Starling; Charlotte Fribbens; Avani Athauda; Diana Tait; Irene Chong; Arabella Hunt; Magnus T. Dillon; Sacheen Kumar; Long R. Jiao; Ricky H. Bhogal; Katharine Aitken
errShare
errSave
Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial
err2026-04-21
err0
errOAAI
errAnderley Gordon; Amina Tran; Caroline Fong; Susan Cromarty; Katarzyna Piadel; Oleg Zhitkov; Becky Leamon; Catherine Cafferkey; Michael Davidson; Prantik Das; Russell Petty; Tom Roques; Madeleine Hewish; Carys Morgan; Tom Waddell; Suzanne Darby; Alexander Bradshaw; Sheela Rao; Naureen Starling; Ian Chau; David Cunningham
errShare
errSave
Correction: Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinoma
err2025-12-19
err0
errOAAI
errKeiji Sugiyama; Sacheen Kumar; Asif Chaudry; Nikhil Patel; Pranav Patel; David Cunningham; Naureen Starling; Sheela Rao; Charlotte Fribbens; Ian Chau
errShare
errSave
Clinical and Molecular Profiling of Colorectal Cancer: A Comprehensive Cohort Study of BRAF-Mutated Cases from a Tertiary Centre
err2025-09-29
err0
errOAAI
errJulia Freckelton; Justin Mencel; Iris Levink; Sheela Rao; Charlotte Fribbens; Paula Proszek; Damian Brooks; Xin Liu; David Cunningham; Ian Chau; Naureen Starling
errShare
errSave
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinoma
err2025-07-14
err0
errOAAI
errKeiji Sugiyama; Sacheen Kumar; Asif Chaudry; Nikhil Patel; Pranav Patel; David Cunningham; Naureen Starling; Sheela Rao; Charlotte Fribbens; Ian Chau
errShare
errSave
The role of PET/CT in peripheral T-cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO-T trial
err2025-05-26
err0
PREAI
errM. Gleeson; C. Gonzalez Arias; D. Cunningham; C. Peckitt; K. Thomas; Y. Du; N. Hujairi; Y. M. To; H. C. Chen; S. Patel; I. Chau; P. Johnson; A. Wotherspoon; A. D. Attygalle; E. A. Hawkes; M. P. Macheta; G. P. Collins; K. Cwynarski; S. Chua
errShare
errSave
Is pathological response an adequate surrogate marker for survival in neoadjuvant therapy with immune checkpoint inhibitors?
err2025-02-01
err0
PREAI
errSugiyama, K.; Gordon, A.; Popat, S.; Okines, A.; Larkin, J.; Chau, I.
errShare
errSave
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypND and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
err2025-02-01
err3
errOAAI
errLordick, F.; Mauer, M. E.; Stocker, G.; Cella, C. A.; Ben-Aharon, I.; Piessen, G.; Wyrwicz, L.; Al-Haidari, G.; Fleitas-Kanonnikoff, T.; Boige, V.; Obermannova, R. Lordick; Martens, U. M.; Gomez-Martin, C.; Thuss-Patience, P.; Arrazubi, V.; Avallone, A.; Shiu, K. K.; Artru, P.; Brenner, B.; Sanchez, C. Buges; Chau, I.; Lorenzen, S.; Daum, S.; Sinn, M.; Merelli, B.; van Grieken, N. C. T.; Nilsson, M.; Collienne, M.; Giraut, A.; Smyth, E.
errShare
errSave
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
err2024-11-25
err0
errOAAI
errSiena, Salvatore; Raghav, Kanwal; Masuishi, Toshiki; Yamaguchi, Kensei; Nishina, Tomohiro; Elez, Elena; Rodriguez, Javier; Chau, Ian; Di Bartolomeo, Maria; Kawakami, Hisato; Suto, Fumitaka; Koga, Makito; Inaki, Koichiro; Kuwahara, Yusuke; Takehara, Issey; Barrios, Daniel; Kobayashi, Kojiro; Grothey, Axel; Yoshino, Takayuki
errShare
errSave
CNS lymphoma imaging and molecular biomarkers study: CLIMB
err2024-09-01
err0
PREAI
errNtellas, P.; Li, S.; Hobbis, L.; Piadel, K.; Cunningham, D.; Macklin-Doherty, A.; El-Sharkawi, D.; Iyengar, S.; Nicholson, E.; Arias, C.; Easdale, S.; Chau, I.
errShare
errSave
Maintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial
err2024-09-01
err1
PREAI
errGordon, A.; Rajan, Z.; Fong, C. Y. K.; Peckitt, C.; Satchwell, L.; Cromarty, S.; Kidd, S.; Piadel, K.; Leamon, B.; Zhitkov, O.; Davidson, M.; Thompson, J.; Maisey, N. R.; Darby, S.; Waddell, T. S.; Morgan, C.; Bradshaw, A.; Starling, N.; Chau, I.; Cunningham, D.
errShare
errSave
Maintenance durvalumab after fi rst-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study
err2024-07-01
err0
errOAAI
errFong, C.; Patel, B.; Peckitt, C.; Bourmpaki, E.; Satchwell, L.; Cromarty, S.; Kidd, S.; von Loga, K.; Uhlik, M.; Begum, R.; Rana, T.; Waddell, T.; Darby, S.; Bradshaw, A.; Roques, T.; Morgan, C.; Rees, C.; Herbertson, R.; Das, P.; Thompson, C.; Hewish, M.; Petty, R.; Thistlethwaite, F.; Rao, S.; Starling, N.; Chau, I.; Cunningham, D.
errShare
errSave
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
err2024-06-12
err2
errOAAI
errSlater, Susanna; Bryant, Annette; Aresu, Maria; Begum, Ruwaida; Chen, Hsiang-Chi; Peckitt, Clare; Lazaro-Alcausi, Retchel; Carter, Paul; Anandappa, Gayathri; Khakoo, Shelize; Melcher, Lucinda; Potter, Vanessa; Marti, Francisca M.; Huang, Joesph; Branagan, Graham; George, Nicol; Abulafi, Muti; Duff, Sarah; Raja, Ashraf; Gupta, Ashish; West, Nicholas; Bucheit, Leslie; Rich, Thereasa; Chau, Ian; Cunningham, David; Starling, Naureen
errShare
errSave
Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients
err2024-06-01
err0
PREAI
errCook, N.; Bridgewater, J. A.; Saunders, M. P.; Kopetz, S.; Garcia-Carbonero, R.; Beom, S-H.; O'Neil, B. H.; Wilson, R. H.; Graham, J.; Maurel, J.; Kim, T. W.; Chau, I.; Saleha, S.; Goodwin, L.; Wilson, D.; Robertson, J.; Timmis, H.; Asken, E.; Woodcock, S. A.; Morris, V.
errShare
errSave
Immunological markers of pathological and clinical and outcomes in mismatch repair deficient (MMRd) colorectal cancer (CRC)
err2024-06-01
err0
PREAI
errChalloner, B. R.; Slater, S. C.; Sansano, H. B.; Aresu, M.; Bryant, A.; Chen, H-C.; Begum, R.; Rana, T.; Zhitkov, O.; Leamon, B.; Barber, L. J.; Peckitt, C.; Chau, I.; Starling, N.; Cunningham, D.; Gerlinger, M.
errShare
errSave
Predictive biomarkers and protein specific mismatch repair (MMR) loss in gastrointestinal (GI) tumours on immune checkpoint inhibitors (ICI): Correlation with survival
err2024-06-01
err0
PREAI
errLe, H. M. L.; Paiva, R. V. D. S.; Farag, S.; Dadouli, K.; Ntellas, P.; Cunningham, D.; Starling, N.; Rao, S.; Fribbens, C.; Chau, I.
errShare
errSave